A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer

被引:21
|
作者
Eladdadi, Amina [1 ]
Isaacson, David [1 ]
机构
[1] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA
关键词
HER2; cell proliferation; receptor modeling; mathematical modeling;
D O I
10.1007/s11538-008-9315-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a mathematical model to study the effects of HER2 over-expression on cell proliferation in breast cancer. The model illustrates the proliferative behavior of cells as a function of HER2 and EGFR receptors numbers, and the growth factor EGF. This mathematical model comprises kinetic equations describing the cell surface binding of EGF growth factor to EGFR and HER2 receptors, coupled to a model for the dependence of cell proliferation rate on growth factor receptors binding. The simulation results from this model predict: (1) a growth advantage associated with excess HER2 receptors; (2) that HER2-over-expression is an insufficient parameter to predict the proliferation response of cancer cells to epidermal growth factors; and (3) the EGFR receptor expression level in HER2-over-expressing cells plays a key role in mediating the proliferation response to receptor-ligand signaling. This mathematical model also elucidates the interaction and roles of other model parameters in determining cell proliferation rate of HER2-over-expressing cells.
引用
收藏
页码:1707 / 1729
页数:23
相关论文
共 50 条
  • [31] EGFR and HER2 overexpression in thoracic cancer
    Gaafar, RM
    Mokhtar, N
    Ismail, H
    Elhosseiny, S
    Abdelhamid, T
    Abdelrahman, AM
    Khaled, HM
    Hassan, N
    LUNG CANCER, 2004, 45 : S35 - S36
  • [32] EGFR and HER2 overexpression in thoracic cancer
    Gaafar, RM
    Mokhtar, N
    Ismail, H
    Elhosseiny, S
    Abdelhamid, T
    Abdelrahman, AM
    Khaled, HM
    Hassan, N
    LUNG CANCER, 2004, 45 : S35 - S35
  • [33] Association of HER2 overexpression and prognosis in small primary breast cancer.
    Schneeweiss, A.
    Schumacher, C.
    Gluz, O.
    Zuna, I.
    Eidt, S.
    Marme, F.
    Nitz, U.
    Sohn, C.
    Rom, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients
    Rikiya Nakamura
    Naohito Yamamoto
    Yasuhide Onai
    Yoshihiro Watanabe
    Hidetada Kawana
    Masaru Miyazaki
    Breast Cancer, 2013, 20 : 336 - 341
  • [35] Epidemiological risk factors for breast cancer and HER2 overexpression in tumors.
    Swede, H
    Moysich, KB
    Freudenheim, JL
    Quirk, JT
    Muti, PC
    Hurd, T
    Edge, SB
    Winston, JS
    Michalek, AM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S103 - S103
  • [36] HER2 overexpression induces sensitivity to moringa isothiocyanates in breast cancer cells
    Olayanju, Julia B.
    Xia, Bing
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Morphological pattern of MR mammography in breast cancer patients with HER2 overexpression
    Artmann, A.
    Boehm, N. A.
    Laemmer-Skarke, I.
    Annecke, K.
    Settles, M.
    Jacobs, V. R.
    Kiechie, M.
    Rummeny, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Polysomy 17 as Predictor of HER2 Gene Overexpression in Breast Cancer Patients
    Al-Abdulwahed, O.
    McMahill, B.
    Zou, Y.
    Saleki, R.
    CYTOGENETIC AND GENOME RESEARCH, 2012, 136 (04) : 351 - 351
  • [39] Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients
    Nakamura, Rikiya
    Yamamoto, Naohito
    Onai, Yasuhide
    Watanabe, Yoshihiro
    Kawana, Hidetada
    Miyazaki, Masaru
    BREAST CANCER, 2013, 20 (04) : 336 - 341
  • [40] Dicer initiates HER2 overexpression in breast cancer, expanding the indications for trastuzumab
    Zhang, Xiaoyun
    Zhang, Xi
    Wu, Jianhua
    Zhang, Jingjing
    Zhang, Zhe
    Sha, Ziyue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 17 (09):